SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TRENTINI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.162
AS - Asia 6.561
EU - Europa 3.863
SA - Sud America 972
AF - Africa 166
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 22.754
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.887
SG - Singapore 2.578
CN - Cina 1.483
IT - Italia 1.059
BR - Brasile 762
VN - Vietnam 745
PL - Polonia 512
DE - Germania 504
HK - Hong Kong 500
GB - Regno Unito 337
FI - Finlandia 281
UA - Ucraina 273
TR - Turchia 266
FR - Francia 212
BD - Bangladesh 190
JP - Giappone 179
IN - India 160
RU - Federazione Russa 140
ID - Indonesia 131
CA - Canada 130
SE - Svezia 121
MX - Messico 100
NL - Olanda 77
AR - Argentina 70
ZA - Sudafrica 60
IQ - Iraq 59
IE - Irlanda 49
BE - Belgio 46
AT - Austria 45
CO - Colombia 44
ES - Italia 42
CZ - Repubblica Ceca 36
EC - Ecuador 31
PK - Pakistan 29
MA - Marocco 27
LT - Lituania 25
PH - Filippine 24
IR - Iran 22
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
SA - Arabia Saudita 20
VE - Venezuela 20
MY - Malesia 19
KR - Corea 18
AU - Australia 16
TW - Taiwan 16
CL - Cile 15
RO - Romania 15
JM - Giamaica 13
KE - Kenya 13
TN - Tunisia 13
EG - Egitto 12
BG - Bulgaria 11
OM - Oman 11
PY - Paraguay 11
NP - Nepal 10
PT - Portogallo 10
AL - Albania 8
CH - Svizzera 8
DZ - Algeria 8
AZ - Azerbaigian 7
ET - Etiopia 7
JO - Giordania 7
KZ - Kazakistan 7
PE - Perù 7
SD - Sudan 7
SI - Slovenia 6
UY - Uruguay 6
BO - Bolivia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
AO - Angola 4
BY - Bielorussia 4
CR - Costa Rica 4
EU - Europa 4
GE - Georgia 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
KW - Kuwait 4
LV - Lettonia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BB - Barbados 3
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
GD - Grenada 3
GR - Grecia 3
HR - Croazia 3
LB - Libano 3
NO - Norvegia 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
Totale 22.714
Salva come PNG Salva come JPEG
Città #
Singapore 1.626
Ashburn 1.436
San Jose 1.066
Fairfield 776
Woodbridge 701
Santa Clara 517
Beijing 505
Ann Arbor 492
Hong Kong 487
Warsaw 478
Chandler 452
Houston 437
Ferrara 347
Jacksonville 319
Dallas 305
Seattle 290
Wilmington 261
Cambridge 251
Ho Chi Minh City 217
Los Angeles 209
New York 197
Council Bluffs 185
Tokyo 171
Izmir 157
Hanoi 153
Helsinki 150
Munich 144
Nanjing 121
Lauterbourg 118
Princeton 115
Menlo Park 98
Jakarta 97
Milan 92
Shanghai 89
Bologna 84
Boardman 81
São Paulo 73
London 67
Mexico City 62
Orem 62
Dearborn 55
San Diego 54
Turku 53
Buffalo 51
Addison 48
Brooklyn 47
Montreal 47
Chennai 44
Brussels 43
Chicago 43
Nanchang 42
Shenyang 40
Toronto 40
Haiphong 39
Johannesburg 39
Bremen 37
Da Nang 36
The Dalles 36
Hefei 35
Nuremberg 35
Frankfurt am Main 34
Tianjin 34
San Francisco 33
Denver 32
Stockholm 32
Poplar 31
Rome 31
Atlanta 30
Boston 30
Phoenix 30
Amsterdam 29
Dong Ket 27
Moscow 27
Vienna 27
Falkenstein 26
Falls Church 26
Manchester 26
Changsha 25
Ankara 24
Brno 24
St Louis 23
Baghdad 22
Belo Horizonte 21
Columbus 21
Jiaxing 21
Mumbai 21
Guangzhou 20
Brasília 19
Paris 19
Hebei 18
Redwood City 18
Rio de Janeiro 18
Tashkent 18
Biên Hòa 16
Curitiba 16
Hải Dương 16
Lappeenranta 16
Norwalk 16
Washington 16
Ningbo 15
Totale 15.300
Salva come PNG Salva come JPEG
Nome #
Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease 337
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 319
Gelatinases, Neurofilaments and N-Acetyl aspartic Acid as Biomarkers in Different Pathologies 307
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia 303
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 297
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 275
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 255
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 253
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 251
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 251
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 250
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 248
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 244
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 244
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 243
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 243
Influence of Vaginal Lactoferrin Administration on Amniotic Fluid Cytokines and its Role Against Inflammatory Complications of Pregnancy 240
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 236
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 236
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 233
Evaluation of a possible role of oxidative stress in climacteric symptoms. 229
Extrapulmonary tuberculosis among immigrants in a low-TB burden and high immigrant receiving city of northern Italy 229
Epidemiologia ed Outcome delle Infezioni della Cute e dei Tessuti Molli Osservate a Ferrara nel Quinquennio 2011-2016 228
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women 228
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 227
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 227
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 219
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 215
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 215
Implication of oxidative stress in dementia: data from cross-sectional and longitudinal study 212
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 212
Leptin/adiponectin ratio predicts post-stroke neurological outcome 209
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 206
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 205
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 202
Serum from patients affected by Alzheimer disease shows a paraoxonase-dependent pro-apoptotic effect on endothelial cells 197
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 195
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 194
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 190
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 188
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 188
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 188
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 188
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 187
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 186
Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts 185
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 184
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 184
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 184
Acute Prosthetic Joint Infections with Poor Outcome Caused by Staphylococcus Aureus Strains Producing the Panton-Valentine Leukocidin 183
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 182
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 181
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 181
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 179
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 176
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 174
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 174
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 171
A Nutraceutical Compound Containing a Low Dose of Monacolin K, Polymethoxyflavones, Phenolic Acids, Flavonoids, and Hydroxytyrosol Improves HDL Functionality 168
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 167
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 167
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 166
Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors 165
null 163
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 162
Fermentation of Vaccinium floribundum Berries with Lactiplantibacillus plantarum Reduces Oxidative Stress in Endothelial Cells and Modulates Macrophages Function 158
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 157
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 155
Brain and serum cholesterol dyshomeostasis during the perimenopausal transition: A possible risk factor for Alzheimer’s disease 155
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease 152
EVALUATION OF THE SWITCH TO A DUAL ART REGIMEN WITH LAMIVUDINE PLUS DOLUTEGRAVIR OR PROTEASE INHIBITORS IN HIV-INFECTED VIROLOGICALLY SUPPRESSED PATIENTS. A REAL LIFE EXPERIENCE 150
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 150
Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia 150
Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment 150
Age, Sex, Hypertension and HDL-C Alter Serum BACE1 Activity in Cognitively Normal Subjects: Implications for Alzheimer's Disease 149
Brain and serum cholesterol metabolism during perimenopausal transition: a risk factor for Alzheimer’s disease? 148
Paraoxonase-1 and dementia-related diseases 146
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis 146
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 146
High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia 144
Purification of transglutaminase enzyme from L. infantum promastigotes 142
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 139
HDL-Cholesterol Subfraction Dimensional Distribution Is Associated with Cardiovascular Disease Risk and Is Predicted by Visceral Adiposity and Dietary Lipid Intake in Women 137
Diaphragmatic dysfunction in critically patients undergoing mechanical ventilation 137
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 136
Paraoxonase 1 activity in patients with Alzheimer disease: Systematic review and meta-analysis 135
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 135
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 134
Clinical and Laboratory Findings in Tick-Borne Encephalitis Virus Infection 132
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines 131
Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease 131
null 128
Inflammation in Neurological Disorders: The Thin Boundary between Brain and Periphery 128
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 128
MMP-9 isoforms in serum of Multiple Sclerosis patients 127
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis 127
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 127
Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia 124
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 124
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 124
Totale 18.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 246
Totale 101.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 0 0 0 0 0 0 0 181 125
2021/20221.247 100 145 155 42 41 75 61 71 37 113 58 349
2022/20231.137 119 104 35 135 174 146 72 111 125 9 65 42
2023/2024864 67 84 37 24 94 98 42 78 44 33 43 220
2024/20253.595 106 98 292 148 442 330 146 211 573 416 466 367
2025/202610.236 909 427 779 1.105 1.381 740 1.543 622 922 1.136 672 0
Totale 23.165